Department of Dermatology
Stefan Esser has not added Biography.
If you are Stefan Esser and would like to personalize this page please email our Author Liaison for assistance.
Treatment of AIDS-related lymphomas: rituximab is beneficial even in severely immunosuppressed patients.
AIDS (London, England) Feb, 2012 | Pubmed ID: 22112600
Lymphocytes proliferate in blood and lymph nodes following interleukin-2 therapy in addition to highly active antiretroviral therapy.
AIDS (London, England) Jan, 2002 | Pubmed ID: 11807298
Double-blind, randomized, placebo-controlled phase III trial of oxymetholone for the treatment of HIV wasting.
AIDS (London, England) Mar, 2003 | Pubmed ID: 12646793
Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
Journal of acquired immune deficiency syndromes (1999) Oct, 2004 | Pubmed ID: 15385733
The steady-state pharmacokinetics of nelfinavir in combination with tenofovir in HIV-infected patients.
Antiviral therapy , 2005 | Pubmed ID: 15865230
Switching to atazanavir improves metabolic disorders in antiretroviral-experienced patients with severe hyperlipidemia.
Journal of acquired immune deficiency syndromes (1999) Jun, 2005 | Pubmed ID: 15905733
[Coronary heart disease associated with the use of highly active antiretroviral therapy (HAART). A case report and review].
Herz Sep, 2005 | Pubmed ID: 16170681
[Staphylococcal infections of the skin and mucous membranes. Guideline of the German Dermatologic Society, Study Group of Dermatologic Infectiology].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG Sep, 2005 | Pubmed ID: 16189866
[Syphilis with HIV coinfection].
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG Oct, 2004 | Pubmed ID: 16281586
Liposomal pegylated doxorubicin versus low-dose recombinant interferon Alfa-2a in the treatment of advanced classic Kaposi's sarcoma; retrospective analysis of three German centers.
Cancer investigation , 2005 | Pubmed ID: 16377582
Carotid intima-media thickness in HIV-infected individuals: relationship of premature atherosclerosis to neuropsychological deficits?
European neurology , 2006 | Pubmed ID: 16733357
Transcranial sonography of the third ventricle and cognitive dysfunction in HIV patients.
Journal of neurology Sep, 2006 | Pubmed ID: 16990993
Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology Dec, 2006 | Pubmed ID: 17179105
Prevalence and natural history of heart failure in outpatient HIV-infected subjects: rationale and design of the HIV-HEART study.
European journal of medical research Jun, 2007 | Pubmed ID: 17666313
Side effects of HIV therapy.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG Sep, 2007 | Pubmed ID: 17760894
Correlation of epidermal nerve fiber density with pain-related evoked potentials in HIV neuropathy.
Pain Aug, 2008 | Pubmed ID: 18096318
Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients.
The Journal of antimicrobial chemotherapy Apr, 2008 | Pubmed ID: 18281305
[Side effects of antiretroviral therapy--skin manifestations].
MMW Fortschritte der Medizin Apr, 2008 | Pubmed ID: 19024907
Evolution of raltegravir resistance during therapy.
The Journal of antimicrobial chemotherapy Jul, 2009 | Pubmed ID: 19447792
"One-stop-shop" staging: should we prefer FDG-PET/CT or MRI for the detection of bone metastases?
European journal of radiology Jun, 2011 | Pubmed ID: 19945240
Lipodystrophy - a sign for metabolic syndrome in patients of the HIV-HEART study.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG Feb, 2010 | Pubmed ID: 20002869
[BNP in HIV-infected patients].
Herz Dec, 2009 | Pubmed ID: 20024643
An epidemiologic study to determine the prevalence of the HLA-B*5701 allele among HIV-positive patients in Europe.
Pharmacogenetics and genomics May, 2010 | Pubmed ID: 20375757
Prevalence of cardiac diastolic dysfunction in HIV-infected patients: results of the HIV-HEART study.
HIV clinical trials May-Jun, 2010 | Pubmed ID: 20739268
Are HIV patients undertreated? Cardiovascular risk factors in HIV: results of the HIV-HEART study.
European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology Feb, 2011 | Pubmed ID: 21450595
HIV prevalence and route of transmission in Turkish immigrants living in North-Rhine Westphalia, Germany.
Medical microbiology and immunology Nov, 2011 | Pubmed ID: 21461764
The SnoB study: frequency of baseline raltegravir resistance mutations prevalence in different non-B subtypes.
Medical microbiology and immunology Nov, 2011 | Pubmed ID: 21475993
Cytochrome P450 2B6 (CYP2B6) and constitutive androstane receptor (CAR) polymorphisms are associated with early discontinuation of efavirenz-containing regimens.
The Journal of antimicrobial chemotherapy Sep, 2011 | Pubmed ID: 21715435
Oral health and the heart - does HIV infection open a pathophysiological gateway?
International journal of cardiology Sep, 2011 | Pubmed ID: 21764468
Improved outcome with rituximab in patients with HIV-associated multicentric Castleman disease.
Blood Sep, 2011 | Pubmed ID: 21778341
Echocardiographic findings and abnormalities in HIV-infected patients: results from a large, prospective, multicenter HIV-heart study.
American journal of cardiovascular disease , 2011 | Pubmed ID: 22254197
How Individual Can Personalized Antiretroviral Treatment Be? Deep Salvage in an HIV-1-Infected Patient.
Intervirology , 2012 | Pubmed ID: 22286888
Detection of abacavir hypersensitivity by ELISpot method.
Inflammation & allergy drug targets Feb, 2012 | Pubmed ID: 22338581
Saleta Sierra1,
Rolf Kaiser1,
Nadine Lübke1,
Alexander Thielen2,
Eugen Schuelter1,
Eva Heger1,
Martin Däumer3,
Stefan Reuter4,
Stefan Esser5,
Gerd Fätkenheuer6,
Herbert Pfister1,
Mark Oette7,
Thomas Lengauer2
1Institute of Virology, University of Cologne,
2, Max Planck Institute for Informatics,
3, Institute for Immune genetics,
4Department of Gastroenterology, Hepatology and Infectiology, University of Duesseldorf,
5Department of Dermatology, University of Essen,
6Department of Internal Medicine, University of Cologne,
7, Augustinerinnen Hospital
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved